Amgen Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Amgen Inc. (AMGN) slid 1.26% to $270.35 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.75% to 3,871.98 and Dow Jones Industrial Average falling 0.39% to 32,732.95. The stock's fall snapped a three-day winning streak. Amgen Inc. closed $4.19 below its 52-week high ($274.54), which the company reached on October 28th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson (JNJ) fell 0.51% to $173.97, Roche Holding AG Part. Cert. fell 1.77% to $331.24, and Pfizer Inc. (PFE) fell 1.86% to $46.55. Trading volume (3.0 M) eclipsed its 50-day average volume of 2.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled October 31, 2022.
(END) Dow Jones Newswires
October 31, 2022 16:37 ET (20:37 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.